why choose us

First received: October 27, 2023

Clinical Trial: Study of the Safety, Pharmacodynamics and Efficacy of ANB-002 in Patients With Hemophilia B (SAFRAN)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Hemophilia B

Study Type: INTERVENTIONAL


Official Title: An Open-label, Non-comparative, Single Dose-Escalation Study of the Safety, Pharmacodynamics and Efficacy of ANB-002 in Patients With Hemophilia B

Brief Summary: The goal of this multicenter, two-stage, open-label study is to investigate the safety, immunogenicity, and efficacy of ANB-002 in subjects with hemophilia ?.The study will have a dose-escalation design with elements of phase I/II seamless adaptive design.

Read more